(2026). Correction to “Highly Specific Cytokine Receptor‐Targeting Chimeras for Targeted Membrane Protein Degradation and Sensitization of Osimertinib in EGFR‐Mutated Non‐Small‐Cell Lung Cancer”. Advanced Materials. https://doi.org/10.1002/adma.73993